Provided by Tiger Trade Technology Pte. Ltd.

Urogen Pharma Ltd.

46.16
-0.7000-1.49%
Post-market: 46.160.00000.00%16:10 EDT
Volume:849.67K
Turnover:39.39M
Market Cap:2.25B
PE:-23.43
High:47.05
Open:46.52
Low:45.27
Close:46.86
52wk High:50.81
52wk Low:15.86
Shares:48.68M
Float Shares:43.35M
Volume Ratio:0.67
T/O Rate:1.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9700
EPS(LYR):-3.1901
ROE:-1481.26%
ROA:-18.06%
PB:-16.97
PE(LYR):-14.47

Loading ...

Aug 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2026

Major Issues Report

Form 8-K - Current report
Aug 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2026

Major Issues Report

Form 8-K - Current report
Jul 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 23, 2026

Major Issues Report

Form 8-K - Current report
Jun 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 02, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2026

Major Issues Report

Form 8-K - Current report
Apr 28, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Mar 02, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2026

Major Issues Report

Form 8-K - Current report
Mar 02, 2026

Major Issues Report

Form 8-K - Current report
Feb 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities